Most Recent
GSK, Novartis concede more ground in ACCC’s Voltaren case
GlaxoSmithKline and Novartis have made another admission in a case brought by the ACCC alleging the drug giants made misleading claims in marketing their Voltaren Osteo Gel and Voltaren Emulgel pain relief products.
VW can’t quash own expert’s dual-mode testimony
Volkswagen lost its bid Tuesday to exclude evidence from its own expert witness it claims has gone off script, an early blow to the car maker in the massive trial alleging it installed dual-mode software in diesel vehicles to cheat on emissions tests.
Saputo in talks to sell milk plant to appease ACCC
Canadian dairy giant Saputo said Monday it is considering selling a milk plant in Victoria to smooth regulatory approval of its proposed $1.3 billion deal to buy Murray Goulburn.
Activ8me pays up for false ACCC endorsement
Teleco provider Activ8me has run afoul of the law by falsely claiming the ACCC gave its internet services the thumbs up, the consumer regulator said Monday.
Taronga Zoo faces court in trade mark battle
Sydney's iconic Taronga Zoo will bare its teeth in court Tuesday for the first hearing in its trade mark battle against the creators of Sydney Zoo, a wildlife reserve in Darling Harbour.
The Reject Shop fined over dangerous projectile toys
The Reject Shop has agreed to pay a penalty of $140,000 and will refund customers who purchased projectile toys that violate consumer protection laws. 
Reckitt Benckiser appeals Nurofen loss
Reckitt Benckiser has filed an appeal against GlaxoSmithKline, after a judge found the consumer goods giant misled consumers with claims that Nurofen was a more effective pain killer than its rival’s Panadol and ordered it to pay all of GlaxoSmithKline’s legal bill.
ACCC serves Woolworths suit over ‘eco’ plates
Australia's consumer regulator has taken Woolworths to court, saying it made deceptive claims to consumers about the biodegradability of its 'eco' line of picnic products. 
Reckitt Benckiser sues P&G over TV commercial
Reckitt Benckiser has brought a claim against its familiar courtroom foe - consumer goods giant Procter & Gamble - over a television commercial and in-store promotion it says violates the consumer laws.
Reckitt Benckiser to feel pain of GSK’s costs in Nurofen case
Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline's legal bill after a judge found the drug giant misled consumers with claims that Nurofen was a more effective pain killer than its rival's Panadol.